Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

1 result

  • Topics : Blood and lymphatic diseases
  • Type : Drugs, devices and medical acts
  • Active substance : eltrombopag
Filter
Topic
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Drug therapy (1)
  • Diseases and conditions (1)
  • Plus ...
    • Infectious diseases (1)
    • Plus ...
      • Virus diseases (1)
    • Congenital, genetic and rare diseases (1)
    • Blood and lymphatic diseases (1)
    • Plus ...
      • Blood coagulation and hemostasis disorders (1)
      • Bone marrow diseases (1)
      • Anemia and hemoglobinopathies (1)
    • Digestive system diseases (1)
    • Plus ...
      • Liver diseases (1)
    • Immune system diseases (1)
    • Plus ...
      • Autoimmune diseases (1)
  • Population groups (1)
  • Plus ...
    • Paediatrics (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Medicine (1)
Date
  • Last five years (1)
Language
  • Français (1)
Active substance
  • eltrombopag (1)
 More filter Other Filter Icon

Drugs, devices and medical acts

  • « Première page
  • < Page précédente
  • / 1
  • > Page suivante
  • » Dernière page
Sorted by :Relevance
  • Title
  • Date

  • REVOLADE (eltrombopag)

    Medicine - Posted on 04/03/2020 - Mis à jour le 4/3/2020
    Add to my selection
  • « Première page
  • < Page précédente
  • / 1
  • > Page suivante
  • » Dernière page
  • 10 par pages
    • 10 par pages
    • 20 par pages
    • 50 par pages
    • 100 par pages

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
kAC3N3VHqWd87DVq